A recent spate of awards shines a light on the strides UTHSC researchers are making in translating their discoveries into novel solutions for human health and well-being. Three licensees, two spinoffs founded by UTHSC researchers and one long-standing partner, have received funding from the highly competitive Small Business Innovation Research (SBIR) and Small Business Technology… Read More
Ramesh Narayanan, PhD, professor in the Department of Medicine and the Division of Hematology and Oncology at the University of Tennessee Health Science Center, has received a $455,000 grant from the National Cancer Institute for a two-year study of the underlying cause of the development of aggressive prostate cancer in African American men. Approximately 174,000… Read More
Nearly five years after beginning their research, investigators from the University of Tennessee Health Science Center, with collaboration from scientists at Oak Ridge National Laboratory (ORNL), have found what they believe will be a next generation treatment option for advanced prostate cancer. Clinical Cancer Research, a high-impact journal in the cancer field, published a paper on… Read More
Ramesh Narayanan, PhD, associate professor in the Department of Medicine-Hematology and adjunct associate professor in the Departments of Urology and Pharmaceutical Sciences at the University of Tennessee Health Science Center (UTHSC), has been awarded over $2 million from the National Institutes of Health (NIH) to develop novel tools and next generation drugs designed to treat… Read More
A team led by Ramesh Narayanan, PhD, MBA, associate professor in the Department of Medicine and director of the Center for Cancer Drug Discovery at the University of Tennessee Health Science Center, has identified a molecule that could eventually lead to a new type of treatment for obesity. A paper by the team detailing the… Read More
